2017 Lymphoma Clinical Research Mentoring Program Provides Research and Professional Development to Early Career Scientists

The fourth year of the Lymphoma Research Foundation’s (LRF), Lymphoma Clinical Research Mentoring Program (LCRMP) convened in mid-March in Washington, D.C. The LCRMP is the Foundation's education and mentoring program for fellows and junior faculty who intend to focus their research and clinical careers in lymphoma and chronic lymphocytic leukemia. Program participants, called LRF Scholars, attend and participate in the intensive introductory workshop, with additional follow-up programming over the subsequent two years, intended to enhance the ability of the Scholars to successfully design and administer clinical research studies, successfully apply for future grant funding, and develop the professional skills to succeed as an independent researcher. Scholars also receive a grant of $10,000 total to support professional development expenses.

Individual profiles of the 2017 LRF Scholars and their workshop projects are linked below. A report on the LCRMP Workshop will be featured in the Spring 2017 edition of the Research Report in April.


Hema Dave, MD, Attending Physician, Children’s Research Institute (Children’s National Medical Center)
Phase 1b Study Utilizing Tumor Associated Antigen Specific T-cells (TAA-T) with PDL1 inhibitor Durvalumab for Relapsed/Refractory Lymphoma (SUSTAIN)

Justine Kahn, MD, Instructor of Pediatrics, Columbia University Medical Center
Outcomes by Race/Ethnicity and Socioeconomic Status in Children and Adolescents with Hodgkin Lymphoma

Neha Mehta-Shah, MD, Assistant Professor, Washington University in St. Louis
A Multi-Institutional Prospective Cohort Study of Minimal Residual Disease in Peripheral T-cell Lymphoma

Sarah Rutherford, MD, Assistant Professor, Weill Cornell Medicine
Abbreviated, Risk-adapted Therapy in Elderly Patients with Newly Diagnosed DLBCL

Jacob Soumerai, MD, Fellow, Medical Oncology and Hematology, Memorial Sloan Kettering Cancer Center
Dual Inhibition of BTK and PI3K-delta with BGB-3111 and ME-401 CLL/SLL and indolent lymphomas

Ashley Staton, MD, Chief Fellow, Emory University-Winship Cancer Institute
Enhancing T Cell Reconstitution with PI3K-delta Inhibitors


Applications for the 2018 LCRMP Workshop will open in late May. Email to receive the grant announcement.

To learn more about the LRF research program, or the research and investigators supported by the Foundation please click here.

To read about other Featured LRF Researchers, including the 2015 and 2016 LRF Scholars click here.